Lupin gets USFDA nod to market generic anti-bacterial drug

The company has received final approval from the US Food and Drug Administration (US FDA) to market metronidazole tablets in strengths of 250 mg and 500 mg, said Lupin.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news